Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.

Posted on by

Related image

“Cannabis when taken orally may represent a way to reduce inflammation and strengthen immune responses.”

https://www.ncbi.nlm.nih.gov/pubmed/30659041  https://bmjopen.bmj.com/content/9/1/e024793

Leave a Reply

Your email address will not be published. Required fields are marked *